Lens-Based Myopia Control: Know When to Treat and Expect Results
Dec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.
Multifocals for Myopia Management – More Than Meets the Eye
Low dose atropine drops, orthokeratology and multifocal contact lenses have all demonstrated success with reducing the rate of myopia progression and in reducing the axial length of the eye. 1-3 Recently, a lens with a multifocal lens design has been approved for the management of myopia progression, the first to receive FDA approval. 4.
Myopia in Adults - Optometry Advisor
Nov 1, 2024 · Axial Elongation in Adult Myopia . Regular eye exams are important for all adults, particularly those experiencing myopia progression. During these visits, it is important for clinicians to measure axial length, due to its association with pathologic myopia. 3 An optical biometer can best measure axial length changes, but not all practices have one. . Among optometry practices that do utilize ...
Soft Multifocal Lenses Affect Accommodation - Optometry Advisor
1 day ago · Soft multifocal lenses affect accommodation and may serve as a promising treatment for accommodation and vergence disorders among patients who have not reached the age of presbyopia onset (age range, 18-30 years), according to a poster presented at the American Academy of Optometry 2024 annual meeting held in Indianapolis from November 6 to 9.
TRPM8 Agonist Increases and Sustains Basal Tear Production
1 day ago · Both studies revealed increased tear production following treatment with the TRPM8 agonist vs vehicle, evidenced by a higher percentage of treatment group participants meeting the primary efficacy endpoint (42.6% vs 8.2% and 53.2% vs 14.4%, respectively; P < .0001 for both), the presenters explain. During the 90-day treatment period, response ...
Presbyopia Drops in the Pipeline for 2023 - Optometry Advisor
Dec 9, 2022 · Presbyopia Drops in the Pipeline for 2023. Topical eye drops are used to treat myriad ocular surface conditions in optometry, but their use as means of managing presbyopia is a novel concept. Michael Dittman, OD, discusses some of the potential advantages of using pilocarpine drops for presbyopia management and the potential benefits of some ...
Red Light Therapy Provides Myopia Control ... - Optometry Advisor
November 22, 2023. As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug ...
Combined Atropine Treatments Show Axial Slowing Efficacy
5 days ago · Combined atropine treatments that use defocus incorporated multiple segments (DIMS) or orthokeratology (ortho-k) in addition to atropine 0.01% can limit axial growth better than combined atropine and single vision lenses, according to a study published in Contact Lens & Anterior Eye.. Researchers included 341 children with low myopia (age range, 6-11 years; −0.50 to −3.0 diopters [D]) who ...
Progressive Lens Designs Can Affect Patient Experience
Jun 7, 2024 · Continuous education in progressive lens technology will serve as a cornerstone in diminishing progressive lens returns, elevating patient satisfaction, and ultimately fostering the success of practices dedicated to presbyopic eye care. For 128 million U.S. presbyopes, doctors of optometry can provide treatment options.
Approaches to Patient Care in Optometry - Optometry Advisor
October 4, 2024. An optometry student can learn a lot in a lab or clinical research setting, but their contact with patients will ultimately guide their clinical decision-making skills and shape their perspectives, according to Andrew Rixon, OD, FAAO, Diplomate (Glaucoma), this year’s recipient of the Vincent Ellerbrock Clinician Educator Award.